You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Phase 2 Study of Temozolomide-Based Chemoradiation Therapy for High-Risk Low-Grade Gliomas: Preliminary Results of Radiation Therapy Oncology Group 0424
|
|---|---|
| Published in |
International Journal of Radiation Oncology, Biology, Physics, January 2015
|
| DOI | 10.1016/j.ijrobp.2014.11.012 |
| Pubmed ID | |
| Authors |
Barbara J. Fisher, Chen Hu, David R. Macdonald, Glenn J. Lesser, Stephen W. Coons, David G. Brachman, Samuel Ryu, Maria Werner-Wasik, Jean-Paul Bahary, Junfeng Liu, Arnab Chakravarti, Minesh Mehta |
| Abstract |
Radiation Therapy Oncology Group (RTOG) 0424 was a phase 2 study of a high-risk low-grade glioma (LGG) population who were treated with temozolomide (TMZ) and radiation therapy (RT), and outcomes were compared to those of historical controls. This study was designed to detect a 43% increase in median survival time (MST) from 40.5 to 57.9 months and a 20% improvement in 3-year overall survival (OS) rate from 54% to 65% at a 10% significance level (1-sided) and 96% power. |
X Demographics
The data shown below were collected from the profiles of 18 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 4 | 22% |
| United States | 3 | 17% |
| Australia | 1 | 6% |
| India | 1 | 6% |
| Latvia | 1 | 6% |
| Unknown | 8 | 44% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 12 | 67% |
| Practitioners (doctors, other healthcare professionals) | 4 | 22% |
| Scientists | 1 | 6% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 163 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 2% |
| Unknown | 160 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 29 | 18% |
| Other | 23 | 14% |
| Student > Postgraduate | 22 | 13% |
| Student > Ph. D. Student | 16 | 10% |
| Student > Doctoral Student | 13 | 8% |
| Other | 32 | 20% |
| Unknown | 28 | 17% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 88 | 54% |
| Neuroscience | 7 | 4% |
| Chemistry | 4 | 2% |
| Nursing and Health Professions | 3 | 2% |
| Physics and Astronomy | 3 | 2% |
| Other | 15 | 9% |
| Unknown | 43 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 108. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 July 2021.
All research outputs
#394,347
of 25,576,801 outputs
Outputs from International Journal of Radiation Oncology, Biology, Physics
#114
of 11,129 outputs
Outputs of similar age
#4,792
of 362,566 outputs
Outputs of similar age from International Journal of Radiation Oncology, Biology, Physics
#1
of 86 outputs
Altmetric has tracked 25,576,801 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,129 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,566 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 86 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.